| 1. | | Recruiting | Benzoylphenylurea in Treating Patients With Advanced Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 2. | | No longer recruiting | Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers
Conditions: recurrent adult acute myeloid leukemia; relapsing chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; ... |
| 3. | | No longer recruiting | Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Conditions: Lymphoma; Leukemia; Multiple Myeloma |
| 4. | | Recruiting | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Immunotherapy in Treating Patients With Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; Philadelphia chromosome positive chronic myelogenous leukemia; ... |
| 5. | | No longer recruiting | Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma
Conditions: Infection; refractory plasma cell neoplasm; stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 6. | | No longer recruiting | Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation
Conditions: Leukemia; Lymphoma |
| 7. | | No longer recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
Conditions: stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer; Quality of Life |
| 8. | | No longer recruiting | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; Quality of Life |
| 9. | | Recruiting | FR901228 Alone or Combined With Rituximab and Fludarabine in Treating Patients With Relapsed or Refractory Low-Grade B-Cell Non-Hodgkin's Lymphoma
Conditions: recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent small lymphocytic lymphoma |
| 10. | | Completed | LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer
Conditions: Lung Cancer; ovarian epithelial cancer; Pancreatic Cancer; ovarian sarcoma; Colon Cancer; Bladder Cancer; Breast Cancer |
| 11. | | No longer recruiting | Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Leukemia; Lymphoma; Multiple Myeloma |
| 12. | | Recruiting | Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: refractory plasma cell neoplasm |
| 13. | | Suspended | Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
Conditions: adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer |
| 14. | | No longer recruiting | Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: Lymphoma; Leukemia; Multiple Myeloma |
| 15. | | No longer recruiting | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
Condition: Lymphoma |
| 16. | | No longer recruiting | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Condition: Lymphocytic Lymphoma |
| 17. | | Completed | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 18. | | Completed | Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 19. | | No longer recruiting | Phase II Study of PSA-3 Peptide Vaccine Emulsified in Montanide ISA-51 in Patients With Recurrent Prostate Cancer
Conditions: adenocarcinoma of the prostate; recurrent prostate cancer |
| 20. | | Completed | R115777 in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia
Conditions: accelerated phase chronic myelogenous leukemia; untreated adult acute myeloid leukemia; untreated adult acute lymphocytic leukemia; ... |
| 21. | | Completed | Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
Conditions: stage IV prostate cancer; recurrent prostate cancer; unspecified adult solid tumor, protocol specific |
| 22. | | Recruiting | UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 23. | | No longer recruiting | ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer
Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer |
